Episode 26. Management of Newly Diagnosed Hodgkin's Lymphoma
Blood Cancer Talks
00:00
The Future of NIVO AVD
I want to ask you again about 1826 and it sounds like you're already building the next trial. One of the things about 1826 is it should shift back to 6 cycles for everyone. Do you think there's a subset of patients where we can give four instead of six? And what do you think the next trial looks like in terms of building on this success of 1826?
Transcript
Play full episode
